EDGAR Filing Documents for 0001628280-23-033914

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001628280-23-033914

Filing Date

2023-10-04

Accepted

2023-10-04 21:40:24

Documents

Period of Report

2023-10-02

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wk-form4_1696470013.html	4
1	FORM 4	wk-form4_1696470013.xml	4	8539
	Complete submission text file	0001628280-23-033914.txt		10151

Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301

Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755

Fresh Tracks Therapeutics, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENDOCYTE, INC., 3000 KENT AVENUE SUITE A1-100 WEST LAFAYETTE IN 47906

Business Address

Type: 4 | Act: 34 | File No.: 000-21088 | Film No.: 231309713